• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

GFR slope as a surrogate marker for future kidney failure.

作者信息

Lees Jennifer S, Mark Patrick B

机构信息

School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.

Glasgow Renal and Transplant Unit, NHS Greater Glasgow and Clyde, Glasgow, UK.

出版信息

Nat Rev Nephrol. 2023 Oct;19(10):625-626. doi: 10.1038/s41581-023-00748-3.

DOI:10.1038/s41581-023-00748-3
PMID:37495682
Abstract
摘要

相似文献

1
GFR slope as a surrogate marker for future kidney failure.肾小球滤过率斜率作为未来肾衰竭的替代标志物。
Nat Rev Nephrol. 2023 Oct;19(10):625-626. doi: 10.1038/s41581-023-00748-3.
2
Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency.白蛋白尿和肾小球滤过率（GFR）变化作为慢性肾脏病（CKD）早期临床试验的终点：美国国家肾脏基金会与美国食品和药物管理局（FDA）及欧洲药品管理局（EMA）合作举办的科学研讨会
Am J Kidney Dis. 2020 Jan;75(1):84-104. doi: 10.1053/j.ajkd.2019.06.009. Epub 2019 Aug 28.
3
A meta-analysis of GFR slope as a surrogate endpoint for kidney failure.一项关于肾小球滤过率（GFR）斜率作为肾衰竭替代终点的荟萃分析。
Nat Med. 2023 Jul;29(7):1867-1876. doi: 10.1038/s41591-023-02418-0. Epub 2023 Jun 17.
4
GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled Trials.GFR 斜率作为临床试验中肾脏疾病进展的替代终点：一项随机对照试验治疗效果的荟萃分析。
J Am Soc Nephrol. 2019 Sep;30(9):1735-1745. doi: 10.1681/ASN.2019010007. Epub 2019 Jul 10.
5
Performance of GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Statistical Simulation.肾小球滤过率斜率作为临床试验中肾脏疾病进展替代终点的性能：统计模拟。
J Am Soc Nephrol. 2019 Sep;30(9):1756-1769. doi: 10.1681/ASN.2019010009. Epub 2019 Jul 10.
6
GFR slope as a surrogate endpoint for CKD progression in clinical trials.肾小球滤过率斜率作为临床试验中慢性肾脏病进展的替代终点。
Curr Opin Nephrol Hypertens. 2020 Nov;29(6):581-590. doi: 10.1097/MNH.0000000000000647.
7
Overview of, and Preparations for, Dialysis.透析概述及准备。
Med Clin North Am. 2023 Jul;107(4):681-687. doi: 10.1016/j.mcna.2023.03.003. Epub 2023 Apr 14.
8
First-year GFR slope and long-term renal outcome in IgA nephropathy.IgA 肾病中肾小球滤过率斜率与长期肾脏预后的关系。
Eur J Clin Invest. 2018 Jun;48(6):e12936. doi: 10.1111/eci.12936. Epub 2018 Apr 30.
9
Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study.糖尿病患者肾功能下降的代谢组学标志物：来自慢性肾功能不全队列（CRIC）研究的证据。
Am J Kidney Dis. 2020 Oct;76(4):511-520. doi: 10.1053/j.ajkd.2020.01.019. Epub 2020 May 5.
10
Estimated GFR Slope Across CKD Stages in Primary Hyperoxaluria Type 1.原发性高草酸尿症 1 型各期慢性肾脏病估计肾小球滤过率斜率。
Am J Kidney Dis. 2022 Sep;80(3):373-382. doi: 10.1053/j.ajkd.2022.01.428. Epub 2022 Mar 16.

引用本文的文献

1
Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease.替代终点在慢性肾脏病治疗管理的卫生技术评估及报销中的应用
EClinicalMedicine. 2025 Aug 29;88:103465. doi: 10.1016/j.eclinm.2025.103465. eCollection 2025 Oct.
2
Systolic blood pressure is associated with early and long-term changes in renal function in patients with dapagliflozin-treated moderate-to-advanced chronic kidney disease.在使用达格列净治疗的中重度慢性肾病患者中，收缩压与肾功能的早期及长期变化相关。
Clin Exp Nephrol. 2025 Apr 16. doi: 10.1007/s10157-025-02678-9.
3

本文引用的文献

1
A meta-analysis of GFR slope as a surrogate endpoint for kidney failure.一项关于肾小球滤过率（GFR）斜率作为肾衰竭替代终点的荟萃分析。
Nat Med. 2023 Jul;29(7):1867-1876. doi: 10.1038/s41591-023-02418-0. Epub 2023 Jun 17.
2
Accuracy of GFR Estimating Equations in Patients with Discordances between Creatinine and Cystatin C-Based Estimations.肾小球滤过率估算方程在肌酐和胱抑素 C 估算值不一致患者中的准确性。
J Am Soc Nephrol. 2023 Jul 1;34(7):1241-1251. doi: 10.1681/ASN.0000000000000128. Epub 2023 Mar 30.
3
A systematic review and meta-analysis of the effect of intravitreal VEGF inhibitors on cardiorenal outcomes.
Renal function decline in Asian patients with atrial fibrillation with warfarin and non-vitamin K antagonist oral anticoagulants: A report from the COOL-AF registry.
亚洲房颤患者使用华法林和非维生素K拮抗剂口服抗凝剂时的肾功能下降：来自COOL-AF注册研究的报告。
J Arrhythm. 2025 Mar 13;41(2):e70037. doi: 10.1002/joa3.70037. eCollection 2025 Apr.
4
The effects of lymphocele formation after living donor kidney transplantation on mid-term allograft function.活体供肾移植后淋巴囊肿形成对移植肾中期功能的影响。
BMC Nephrol. 2025 Feb 6;26(1):59. doi: 10.1186/s12882-025-03989-5.
一项关于玻璃体内血管内皮生长因子抑制剂对心肾结局影响的系统评价和荟萃分析。
Nephrol Dial Transplant. 2023 Jun 30;38(7):1666-1681. doi: 10.1093/ndt/gfac305.
4
Sex Differences in Age-Related Loss of Kidney Function.年龄相关的肾功能丧失中的性别差异。
J Am Soc Nephrol. 2022 Oct;33(10):1891-1902. doi: 10.1681/ASN.2022030323. Epub 2022 Aug 17.
5
Incidence and Predictors of CKD and Estimated GFR Decline in Patients Receiving Immune Checkpoint Inhibitors.接受免疫检查点抑制剂治疗的患者中慢性肾脏病的发病率及预测因素和估计肾小球滤过率下降情况
Am J Kidney Dis. 2022 Jan;79(1):134-137. doi: 10.1053/j.ajkd.2021.05.012. Epub 2021 Jun 24.
6
GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled Trials.GFR 斜率作为临床试验中肾脏疾病进展的替代终点：一项随机对照试验治疗效果的荟萃分析。
J Am Soc Nephrol. 2019 Sep;30(9):1735-1745. doi: 10.1681/ASN.2019010007. Epub 2019 Jul 10.
7
Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories.预测 250 种死因的预期寿命、损失的生命年数以及全因和特定死因死亡率：2016-2040 年 195 个国家和地区的参考和替代情景。
Lancet. 2018 Nov 10;392(10159):2052-2090. doi: 10.1016/S0140-6736(18)31694-5. Epub 2018 Oct 16.
8
Use of surrogate outcomes in US FDA drug approvals, 2003-2012: a survey.2003 - 2012年美国食品药品监督管理局药物批准中替代终点的使用情况：一项调查
BMJ Open. 2015 Nov 27;5(11):e007960. doi: 10.1136/bmjopen-2015-007960.
9
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.罗格列酮对心肌梗死风险及心血管原因所致死亡的影响。
N Engl J Med. 2007 Jun 14;356(24):2457-71. doi: 10.1056/NEJMoa072761. Epub 2007 May 21.
10
Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization.大型管理式医疗组织中慢性肾脏病患者群体的纵向随访及结局
Arch Intern Med. 2004 Mar 22;164(6):659-63. doi: 10.1001/archinte.164.6.659.